15 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Genomas Competitors or Alternatives

Genomas's top competitors include Esperion, Cardialen and Regeneron.

Unlock 25 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Genomas's company profile

Gualberto Ruaño

President & CEO

69/100
100 - 250
$500K
$100K - 5M
  • $500K
    $100K - 5M
  • 100 - 250
    $500K
  • $100K - 5M
  • 69/100
  • 100 - 250
  • $500K
  • $100K - 5M
View ProfileView
1
Genomas's Competitor - Esperion logo

Sheldon Koenig

President & CEO

83/100
200
$845.4M
$418.2M
  • $845.4M
    $418.2M
  • 200
    $845.4M
  • $418.2M
  • 83/100
  • 200
  • $845.4M
  • $418.2M
View ProfileView
2
Genomas's Competitor - Cardialen logo

Jeff Peters

President & CEO

84/100
25 - 100
$34M
$5M - 25M
  • $34M
    $5M - 25M
  • 25 - 100
    $34M
  • $5M - 25M
  • 84/100
  • 25 - 100
  • $34M
  • $5M - 25M
View ProfileView
3
Genomas's Competitor - Regeneron logo

Leonard S. Schleifer

President & CEO

58/100
11,900
$2.1B
$15.5B
  • $2.1B
    $15.5B
  • 11,900
    $2.1B
  • $15.5B
  • 58/100
  • 11,900
  • $2.1B
  • $15.5B
View ProfileView
4
Genomas's Competitor - Daiichi Sankyo logo

Hiroyuki Okuzawa

President & CEO

82/100
19,765
- -
$13.4B
  • - -
    $13.4B
  • 19,765
    - -
  • $13.4B
  • 82/100
  • 19,765
  • - -
  • $13.4B
View ProfileView
5
Genomas's Competitor - Kardium logo

Kevin Chaplin

CEO

88/100
250 - 500
$501.4M
$25M - 100M
  • $501.4M
    $25M - 100M
  • 250 - 500
    $501.4M
  • $25M - 100M
  • 88/100
  • 250 - 500
  • $501.4M
  • $25M - 100M
View ProfileView
Genomas' top 28 competitors are Esperion, Cardialen, Regeneron, Gemphire Therapeutics, Daiichi Sankyo, Kardium, Amryt Pharma, The Medicines Company, CardioFocus, BioVentrix, Amarin, Sanofi, Amgen, PhaseBio, CSI, AbbVie, Curative Medical, PanOptica, QT Vascular, AtriCure, Trygg Pharma As, Ra Pharma, Attune, Oscor, Lilly, Sanifit, Baylis Medical and Acasti Pharma. Together they have raised over 34.7B between their estimated 233.8K employees. Genomas's revenue is the ranked 24th among it's top 10 competitors. The top 10 competitors average 9.1B. Genomas has 100 employees and is ranked 15th among it's top 10 competitors. The top 10 competitors average 8,663.

Genomas VS Esperion

Esperion has been one of Genomas's top competitors. Esperion is a Public company that was founded in 1998 in Ann Arbor, Michigan. Like Genomas, Esperion also competes in the Pharmaceuticals sector. Compared to Genomas, Esperion has 100 more employees.

Genomas VS Cardialen

Cardialen is seen as one of Genomas's biggest rivals. Cardialen is a Private company that was founded in Minneapolis, Minnesota in 2008. Like Genomas, Cardialen also operates in the Pharmaceuticals & Biotechnology sector. Cardialen has 72 fewer employees vs. Genomas.

Genomas VS Regeneron

Regeneron is perceived as one of Genomas's biggest rivals. Regeneron was founded in Tarrytown, New York} in 1988. Like Genomas, Regeneron also competes in the Pharmaceuticals & Biotechnology space. Compared to Genomas, Regeneron generates $15.5B more revenue.

Looking for similar companies to Genomas?

Similar Companies

Pharmaceuticals companies in Greater Hartford

See 58 companies 
Companies in Hartford with employees in 100-250 range

See 100 companies 
Pharmaceuticals companies in Connecticut

See 105 companies 
Pharmaceuticals & Biotechnology companies in Greater Hartford

See 133 companies 
Pharmaceuticals & Biotechnology companies in Connecticut

See 211 companies 
Companies in Hartford with revenue in $100K-5.0M range

See 436 companies 
Pharmaceuticals companies with employees in 100-250 range

See 820 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,822 companies 
Pharmaceuticals companies with revenue in $100K-5.0M range

See 2,189 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Genomas and Genomas's Competitors

October 10, 2026Ad-hoc-news
Amgen was quoted at USD 414.87 on October 9, 2026. The quote was up 1.82 percent from USD 407.44. Amgen's investor relations page lists a September 22 ...
Today 12:43 AMProactiveinvestors
In brief Amgen Inc is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesse...

Frequently Asked Questions about Genomas

  1. Who are Genomas's top competitors?

    Genomas's top 3 competitors are Esperion, Cardialen, Regeneron.

  2. Who is similar to Genomas?

    Esperion is the most similar to Genomas. Cardialen and Regeneron are also similar to Genomas.

  1. Are Genomas and Esperion competitors?

    Yes, Esperion is one of Genomas’s top competitors.